The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reduction of Capital effective

4 Dec 2020 10:00

RNS Number : 6046H
Plutus PowerGen PLC
04 December 2020
 

4 December 2020

PLUTUS POWERGEN PLC

("Plutus", the "Group" or the "Company")

 

Reduction of Capital effective

 

Further to the announcement made by the Company on the 24 November 2020, the Board of Plutus today announces that the Reduction of Capital required to effect the demerger of Plutus Energy Limited has become effective. This follows the Court Order approving the Reduction of Capital having been registered with Companies House.

 

Completion of the Proposals remain subject only to the admission of the Placing Shares and Debt Capitalisation Shares to trading on AIM.

 

Pursuant to the previously announced Proposals, the Company has conditionally raised £600,000 (before expenses) through a placing of 3,000,000,000 new Ordinary Shares at a price of 0.02p per Ordinary Share and has undertaken a debt capitalisation which will result in the issue of 1,390,470,000 new Ordinary shares at a conversion price of 0.02p per new Ordinary Shares (the "New Ordinary Shares").

 

Application will be made shortly to the London Stock Exchange for the 4,390,470,000 New Ordinary Shares pursuant to the Placing and Debt Capitalisation to be admitted to trading on AIM and it is expected that admission will take place on or around 10 December 2020 ("Admission").

 

AIM Rule 15 Cash Shell

Following the completion of the demerger of Plutus Energy Limited, the Company will become an AIM Rule 15 Cash Shell and, in accordance with Rule 15 of the AIM Rules, the Company will be required to make an acquisition, or acquisitions, which constitutes a reverse takeover under AIM Rule 14 (including seeking re-admission under the AIM Rules for Companies) within six months from becoming an AIM Rule 15 Cash Shell. Alternatively, within such time period, the Company can seek to become an investing company pursuant to AIM Rule 8, which requires, inter alia, the raising of at least £6 million and publication of an admission document. In the event that the Company does not complete a reverse takeover under AIM Rule 14 within such six month period or seek re-admission to trading on AIM as an investing company pursuant to AIM Rule 8 (either being, a "Re-admission Transaction"), the Company's ordinary shares would be suspended from trading pursuant to AIM Rule 40. Thereafter, if a Re-admission Transaction has not been completed within a further six month period, admission to trading on AIM of the Company's ordinary shares would be cancelled.

 

Total Voting Rights

Upon Admission of the New Ordinary Shares, the issued share capital of the Company will consist of 5,263,004,994 ordinary shares of 0.01p each. The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company from Admission will be 5,263,004,994. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

An updated timetable of events is set out below:

 

Expected date of the completion of the Demerger

10 December 2020

Admission of the Placing Shares and Debt Capitalisation Shares to trading on AIM

 

on or around 10 December 2020

CREST stock accounts to be credited for the Placing Shares in uncertificated form

 

on or around 10 December 2020

 

Dispatch of share certificates in certificated form by no later than

17 December 2020

 

Further announcements will be made in due course.

Definitions in this announcement are consistent with those set out in the circular issued to Shareholders of the Company on 9 October 2020, a copy of which is available on the investor section of the Company's current website (http://www.plutuspowergenplc.com).

 

For further information, please contact:

Plutus PowerGen PLC

Charles Tatnall, Executive Chairman

James Longley, Interim CEO and Finance Director

 

 

Tel: +44 (0) 20 8720 6562

 

Allenby Capital (Nominated Adviser and Joint Broker)

Nick Athanas

Nick Naylor

James Hornigold

 

 

Tel: +44 (0)20 3328 5656

Turner Pope Investments (TPI) Limited (Joint Broker)

Andy Thacker

 

 

  Tel: +44 (0) 20 3657 0050

St Brides Partners Limited (Financial PR)

Isabel de Salis

Cosima Akerman

 

Tel: +44 (0)20 7236 1177

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANALESFEFEA
Date   Source Headline
20th Sep 20211:00 pmRNSUpdate
23rd Aug 20214:30 pmRNSUpdate re: Nominated Adviser
20th Aug 20212:00 pmRNSUpdate re: Nominated Adviser
11th Jun 20217:30 amRNSSuspension - Plutus Powergen plc
11th Jun 20217:00 amRNSProposed Reverse Takeover & Suspension of Trading
19th May 20214:18 pmRNSResult of AGM
22nd Apr 20214:09 pmRNSNotice of AGM
8th Mar 202111:17 amRNSHolding(s) in Company
5th Feb 202111:03 amRNSHalf-year Report
29th Jan 20215:09 pmRNSFinal Results
28th Jan 20217:00 amRNSConvertible loan note
8th Jan 20212:58 pmRNSStatement re share price movement
8th Jan 20217:00 amRNSAppointment of Joint Broker
31st Dec 20201:00 pmRNSTotal Voting Rights
10th Dec 20209:30 amRNSDemerger, Admission of Shares & AIM Rule 15 status
4th Dec 202010:00 amRNSReduction of Capital effective
24th Nov 20205:42 pmRNSReduction of Capital approved by the Court
19th Nov 20206:15 pmRNSPlutus Powergen
6th Nov 202011:00 amRNSFurther re Capital Reorganisation
3rd Nov 202011:59 amRNSResult of General Meeting & Further re Demerger
9th Oct 20204:28 pmRNSProposed demerger, placing, notice of GM & update
29th Jun 20207:00 amRNSNew Website Address
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
3rd Apr 202011:26 amRNSHolding(s) in Company
1st Apr 20207:00 amRNSCorporate Update
29th Jan 20207:00 amRNSInterim Results
27th Jan 202010:24 amRNSHolding(s) in Company
22nd Jan 20207:00 amRNSLoan agreement and related party transaction
10th Jan 202012:50 pmRNSResult of General Meeting
10th Jan 202010:59 amRNSResult of AGM
13th Dec 20197:00 amRNSNotice of GM & AGM
21st Nov 20191:29 pmRNSRequisition of General Meeting
19th Nov 20197:00 amRNSOperational and financial update
13th Nov 20195:05 pmRNSReceipt of purported notice of requisition of GM
12th Nov 20194:04 pmRNSDirector holdings & Update on Director Dealings
31st Oct 20196:38 pmRNSFinal Results
30th Oct 20197:00 amRNSBoard update
25th Oct 201911:28 amRNSStatement on Capacity Market EC ruling
21st Oct 20197:00 amRNSBoard update
3rd Sep 20192:02 pmRNSUpdate re Planning Permission Application
29th Aug 20197:00 amRNSAgreement for Gas Site Funding and Rockpool update
12th Aug 20197:00 amRNSSupport to UK National Grid in latest power crisis
31st Jul 20195:00 pmRNSTotal Voting Rights
31st Jul 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20194:00 pmRNSHolding(s) in Company
24th Jul 20195:23 pmRNSHolding(s) in Company
18th Jul 20196:00 pmRNSUpdate on Issue of Equity
16th Jul 20197:00 amRNSIssue of Equity
27th Jun 20192:01 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.